Kevin Ali is Chief Executive Officer of Organon & Co.. Currently has a direct ownership of 199,919 shares of OGN, which is worth approximately $3.09 Million. The most recent transaction as insider was on Feb 20, 2025, when has been sold 55,104 shares (Common Stock) at a price of $15.11 per share, resulting in proceeds of $832,621. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200K
37.98% 3M change
294.95% 12M change
Total Value Held $3.09 Million

Kevin Ali Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2025
SELL
Payment of exercise price or tax liability
$832,621 $15.11 p/Share
55,104 Reduced 21.61%
199,919 Common Stock
Feb 20 2025
BUY
Grant, award, or other acquisition
-
99,645 Added 33.48%
197,958 Common Stock
Sep 03 2024
SELL
Payment of exercise price or tax liability
$242,714 $20.35 p/Share
11,927 Reduced 7.61%
144,888 Common Stock
Sep 03 2024
BUY
Grant, award, or other acquisition
-
21,567 Added 12.09%
156,815 Common Stock
May 04 2024
SELL
Payment of exercise price or tax liability
$240,340 $19.61 p/Share
12,256 Reduced 8.31%
135,248 Common Stock
May 04 2024
BUY
Exercise of conversion of derivative security
-
22,161 Added 13.06%
147,504 Common Stock
Mar 31 2024
SELL
Payment of exercise price or tax liability
$628,427 $18.8 p/Share
33,427 Reduced 21.05%
125,343 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
60,444 Added 29.15%
146,896 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$729,068 $18.04 p/Share
40,414 Reduced 29.13%
98,326 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
88,121 Added 38.84%
138,740 Common Stock
May 04 2023
SELL
Payment of exercise price or tax liability
$297,036 $24.24 p/Share
12,254 Reduced 19.49%
50,619 Common Stock
May 04 2023
BUY
Exercise of conversion of derivative security
-
22,158 Added 26.06%
62,873 Common Stock
May 01 2023
SELL
Payment of exercise price or tax liability
$36,723 $24.63 p/Share
1,491 Reduced 3.53%
40,715 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
-
2,711 Added 6.04%
42,206 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$274,655 $23.09 p/Share
11,895 Reduced 23.15%
39,495 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
21,471 Added 29.47%
51,390 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$160,249 $25.09 p/Share
6,387 Reduced 17.59%
29,919 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
11,393 Added 23.89%
36,306 Common Stock
May 04 2022
SELL
Payment of exercise price or tax liability
$397,520 $32.44 p/Share
12,254 Reduced 32.97%
24,913 Common Stock
May 04 2022
BUY
Exercise of conversion of derivative security
-
22,158 Added 37.35%
37,167 Common Stock
May 03 2022
SELL
Payment of exercise price or tax liability
$40,742 $32.08 p/Share
1,270 Reduced 7.8%
15,009 Common Stock
May 03 2022
BUY
Exercise of conversion of derivative security
-
2,631 Added 13.91%
16,279 Common Stock
May 01 2022
SELL
Payment of exercise price or tax liability
$49,239 $32.33 p/Share
1,523 Reduced 10.04%
13,648 Common Stock
May 01 2022
BUY
Exercise of conversion of derivative security
-
2,709 Added 15.15%
15,171 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$243,040 $37.57 p/Share
6,469 Reduced 34.17%
12,462 Common Stock
KA

Kevin Ali

Chief Executive Officer
Kenilworth, NJ

Track Institutional and Insider Activities on OGN

Follow Organon & Co. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

News

Receive news related to Organon & Co.

Track Activities on OGN